Back to compounds

COMPOUND PROFILE / PEPTIDES & ANALOGUES

Colivelin.

Research draft

Colivelin is an experimental Humanin-related hybrid peptide.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Colivelin is an experimental Humanin-related hybrid peptide.

CLASSIFICATIONPeptides & analogues
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

Cell studies investigate neuroprotective signalling, including JAK/STAT pathways.

Human research

A therapeutic human evidence base was not established.

Preclinical & other research

Neuron and animal-injury models examined survival and axonal responses.

Safety & unknowns

Human exposure, immunogenicity and long-term safety are not established.

Regulatory status

Preclinical research candidate; component similarity does not validate Humanin-equivalent effects.

Reported use & evidence

Research profile draft

The supplied Colivelin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Follow the cited records and registered research. Profiles remain research drafts.

Explore more compounds